1. Home
  2. BLFS vs PBMWW Comparison

BLFS vs PBMWW Comparison

Compare BLFS & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • PBMWW
  • Stock Information
  • Founded
  • BLFS 1987
  • PBMWW N/A
  • Country
  • BLFS United States
  • PBMWW Canada
  • Employees
  • BLFS N/A
  • PBMWW 10
  • Industry
  • BLFS Medical/Dental Instruments
  • PBMWW
  • Sector
  • BLFS Health Care
  • PBMWW
  • Exchange
  • BLFS Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • BLFS N/A
  • PBMWW N/A
  • IPO Year
  • BLFS 1989
  • PBMWW N/A
  • Fundamental
  • Price
  • BLFS $21.65
  • PBMWW $0.01
  • Analyst Decision
  • BLFS Strong Buy
  • PBMWW
  • Analyst Count
  • BLFS 6
  • PBMWW 0
  • Target Price
  • BLFS $27.83
  • PBMWW N/A
  • AVG Volume (30 Days)
  • BLFS 407.6K
  • PBMWW N/A
  • Earning Date
  • BLFS 11-12-2024
  • PBMWW N/A
  • Dividend Yield
  • BLFS N/A
  • PBMWW N/A
  • EPS Growth
  • BLFS N/A
  • PBMWW N/A
  • EPS
  • BLFS N/A
  • PBMWW N/A
  • Revenue
  • BLFS $146,957,000.00
  • PBMWW N/A
  • Revenue This Year
  • BLFS N/A
  • PBMWW N/A
  • Revenue Next Year
  • BLFS $8.56
  • PBMWW N/A
  • P/E Ratio
  • BLFS N/A
  • PBMWW N/A
  • Revenue Growth
  • BLFS 16.40
  • PBMWW N/A
  • 52 Week Low
  • BLFS $11.40
  • PBMWW N/A
  • 52 Week High
  • BLFS $28.88
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 36.78
  • PBMWW N/A
  • Support Level
  • BLFS $25.77
  • PBMWW N/A
  • Resistance Level
  • BLFS $28.88
  • PBMWW N/A
  • Average True Range (ATR)
  • BLFS 1.52
  • PBMWW 0.00
  • MACD
  • BLFS -0.12
  • PBMWW 0.00
  • Stochastic Oscillator
  • BLFS 6.95
  • PBMWW 0.00

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: